Development of aseptic subcutaneous abscess after tocilizumab therapy in a patient with SAPHO syndrome complicated by amyloid A amyloidosis

Int J Rheum Dis. 2015 May;18(4):476-9. doi: 10.1111/1756-185X.12525. Epub 2014 Dec 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abscess / etiology
  • Abscess / physiopathology*
  • Acquired Hyperostosis Syndrome / complications
  • Acquired Hyperostosis Syndrome / diagnosis
  • Acquired Hyperostosis Syndrome / drug therapy*
  • Aged
  • Amyloidosis / diagnosis*
  • Amyloidosis / therapy
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Disease Progression
  • Follow-Up Studies
  • Humans
  • Male
  • Rare Diseases
  • Renal Insufficiency / etiology*
  • Renal Insufficiency / physiopathology
  • Renal Insufficiency / therapy
  • Risk Assessment
  • Serum Amyloid A Protein / metabolism
  • Severity of Illness Index
  • Skin Diseases / etiology
  • Skin Diseases / physiopathology*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Serum Amyloid A Protein
  • tocilizumab